ACTINIUM PHARMACEUTICALS, INC. Decrease in Restricted Cash
ACTINIUM PHARMACEUTICALS, INC. (ATNM) reported Decrease in Restricted Cash of $34.73 thousand for the 3-month period ending 2017-03-31, per its 10-Q filed 2017-05-15.
Discontinued › Notes
us-gaap:DecreaseInRestrictedCash · last filed 2017-05-15
- ACTINIUM PHARMACEUTICALS, INC. decrease in restricted cash for the quarter ending 2017-03-31 was $34.73K.
| Period end | Decrease in Restricted Cash 3 month |
|---|---|
| 2017-03-31 | $34.73K 10-Q · filed 2017-05-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 |